Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
1.350
+0.130 (10.66%)
At close: Apr 14, 2026, 4:00 PM EDT
1.320
-0.030 (-2.22%)
After-hours: Apr 14, 2026, 7:59 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $15.96 million as of April 14, 2026. Its market cap has decreased by -12.87% in one year.
Market Cap
15.96M
Enterprise Value
25.37M
1-Year Change
-12.87%
Ranking
Category
Stock Price
$1.35
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $15.96M, a decrease of -84.58%. That is a compound annual growth rate of -29.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 15.96M | -12.53% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TELA Bio | 25.39M |
| Lifeward | 24.87M |
| Modular Medical | 22.88M |
| Pulsenmore | 22.37M |
| Inspira Technologies Oxy B.H.N. | 18.52M |
| IRIDEX | 17.31M |
| Trinity Biotech | 13.37M |
| Sintx Technologies | 11.05M |